Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Acute LDL-C Reduction Post ACS: Strike Early and Strike Strong: From Evidence to Clinical Practice

Treatment simplification of complex insulin regimens in T2D

Treatment simplification of complex insulin regimens in T2D

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Insulin advancement in Type 2 diabetes: Unmet needs with commonly-used options

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Glargine 300 use in people with type 2 diabetes who fast during Ramadan

Gaucher

Gaucher

Challenges associated with commonly-used insulin advancement options

Challenges associated with commonly-used insulin advancement options

Better care for Fabry

Better care for Fabry

Every Moment Matters on the Fabry Journey

EVOLUTION: RWE from Saudi Arabia

EVOLUTION: RWE from Saudi Arabia

How To Diagnose LSDs?

How To Diagnose LSDs?

Learn more about early diagnosis of lysosomal storage disorders: Fabry disease, Pompe Disease, Gaucher disease, Acid Sphingomyelinase Deficiency (ASMD, also known as Niemann-Pick Type A/B), mucopolysaccharidoses (MPSs).

Inside Diabetes: ATTD Edition | Type 1 Diabetes

Inside Diabetes: ATTD Edition | Type 1 Diabetes

ROLE OF ECG IN DIFFERENTIAL DIAGNOSIS OF ANDERSON–FABRY DISEASE WITH HCM

ROLE OF ECG IN DIFFERENTIAL DIAGNOSIS OF ANDERSON–FABRY DISEASE WITH HCM

DIAGNOSING FABRY DISEASE IN CLINICAL PRACTICE

DIAGNOSING FABRY DISEASE IN CLINICAL PRACTICE